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Abstract.  All Ca2+-dependent cell adhesion molecules 
are synthesized as precursor polypeptides followed by 
a  series of posttranslational modifications including 
proteolytic cleavage. The mature proteins are formed 
intracellularly and transported to the cell surface. For 
uvomorulin the precursor segment is composed of 
129-amino acid residues which are cleaved off to 
generate the  120-kD  mature protein.  To elucidate the 
role of proteolytic processing,  we constructed cDNAs 
encoding mutant uvomorulin that could no longer be 
processed by endogenous proteolytic enzymes and ex- 
pressed the mutant polypeptides in L  cells. Instead of 
the recognition sites for endogenous proteases, these 
mutants contained either a  recognition site of serum 
coagulation factor Xa or a new trypsin cleavage site. 
The intracellular proteolytic processing of mutant 
polypeptides was inhibited in both cases.  The un- 
processed polypeptides were efficiently expressed on 
the cell surface and had other features in common 
with mature uvomorulin, such as complex formation 
with catenins and Ca2+-dependent resistance to proteo- 
lytic degradation.  However, cells expressing un- 
processed polypeptides showed no uvomorulin- 
mediated adhesive function. Treatment of the mutant 
proteins with the respective proteases results in cleav- 
age of the precursor region and the activation of 
uvomorulin function. However, other proteases al- 
though removing the precursor segment were ineffec- 
tive in activating the adhesive function. These results 
indicate that correct processing is required for 
uvomorulin function and emphasize the importance of 
the amino-terminal region of mature uvomorulin poly- 
peptide in the molecular mechanism of adhesion. 
T 
HE  cell  adhesion  molecule  (CAM) 1 uvomorulin  is 
synthesized as a precursor polypeptide of 135 kD fol- 
lowed by a series of posttranslational modifications in- 
cluding proteolytic processing, glycosylation, and phospho- 
rylation (Peyri6ras  et  al.,  1983;  Vestweber  and  Kemler, 
1984). The mature form of uvomorulin is formed intracellu- 
larly and transported to the cell surface. During these pro- 
cesses  the  cytoplasmic  domain of uvomorulin associates 
with three proteins (102,  88, and 80 kD) named catenin c~, 
/3, and 3', respectively (Ozawa et al.,  1989).  The uvomoru- 
lin-catenin complex formation has recently been found to 
play an important role for uvomorulin function and the con- 
nection of the protein to actin (Ozawa et al.,  1990). 
Ca2+-dependent CAMs consist of a gene family of struc- 
turally and functionally related molecules which exhibit a 
remarkable similar topology as revealed by secondary struc- 
ture predictions (Takeichi,  1988; Hatta et al., 1988; Kemler 
et al., 1989).  Members of this group express their adhesive 
properties only in the presence of Ca  2+, and Ca  2÷ protects 
these proteins from proteolytic degradation (Takeichi,  1977; 
Hyafil et al.,  1981; Gallin et al.,  1983).  The extracellular 
parts of the proteins are largely composed of repeating do- 
mains, each domain with two putative Ca2+-binding motifs 
1. Abbreviation  used in this paper:  CAM, cell adhesion molecule. 
which are well conserved and at analogous positions in all 
proteins.  All  Ca2+-dependent  CAMs  are  synthesized  as 
precursor polypeptides, but in contrast to the extended ho- 
mology between the mature proteins the respective precur- 
sor segments show no structural similarity. Each precursor 
segment varies in length and sequence comparison reveals a 
rather weak homology, of 28--40% at the nucleotide level. 
However, precursor segments of mouse uvomorulin, chicken 
L-CAM (Gallin et al.,  1986;  1987),  mouse P- (Nose et al., 
1987), and chicken N-cadherins (Hatta et al., 1988) all ter- 
minate in the sequence Leu-(Arg/Lys)-Arg-(Gln/Arg)-Lys- 
Arg and the respective mature proteins all have the amino- 
terminal sequence  (Asp/Glu)-Trp-Val-(Ile/Met)-Pro-Pro-Ile 
in common, suggesting that proteases of similar specificities 
are involved in processing. 
Proteolytic processing is a common and effective mecha- 
nism of physiological regulation. In general, proteolytic pro- 
cessing releases a  conformational restraint on an inactive 
precursor to generate a biologically active protein (for re- 
view see Neurath, 1989). The role of proteolytic cleavage in 
the activation of viral glycoproteins has been defined for 
some viral glycoproteins such as the F  (fusion) protein of 
Sendai or the hemagglutinin (HA) protein of influenza virus 
(Homma and Ohuchi, 1973;  for review see Wiley and Ske- 
hel, 1987). In each case proteolytic cleavage of the precursor 
©  The Rockefeller University Press, 0021-9525/90/10/1645/6 $2.00 
The Journal of Cell Biology, Volume 111, October  1990  1645-1650  1645 protein creates on the transmembrane subunit a new hydro- 
phobic amino-terminal domain (25-30 amino acid residues), 
"the fusion peptide" which is implicated in the fusion activ- 
ity of the protein (Gething et al., 1978; for review see Wiley 
and Skehel,  1987). 
We have been interested in the role proteolytic processing 
might have on the assembly of the uvomorulin-catenin com- 
plex, cell surface expression, and adhesive function. For this 
we have constructed cDNA  in  which the endoproteolytic 
cleavage  site  (Arg-Arg-Gln-Lys-Arg)  was  replaced  by  a 
cleavage site for serum coagulation factor Xa (Arg-Ile-Glu- 
Gly-Arg). In a second eDNA construct we replaced the en- 
dogenous cleavage site by amino acid residues Arg-Thr-Gln- 
Thr-Arg  following  a  similar  substitution  strategy,  which 
blocked the processing of hemagglutinin and which could be 
cleaved by trypsin (Kawaoka and Webster, 1988). We show 
that  unprocessed  uvomorulin has  most  characteristics  in 
common with the mature protein but exhibits no adhesive 
function. Protease treatment converts the unprocessed form 
into mature protein which has adhesive properties. However, 
exact cleavage is necessary for the activation of the adhesive 
function. 
Materials and Methods 
cDNA Construction 
Plasmid pSUM-1 with full-length uvomorulin eDNA has been described 
(Ozawa et al., 1989).  cDNAs encoding uvomorulin polypeptides with sub- 
stitutions in the putative endoprotenlytic cleavage site were constructed as 
schematically outlined in Fig.  1. A 30-bp Rsa I-Tth III I fragment coding 
for 10 amino acid residues with the endoproteolytic cleavage site was re- 
placed by one of the following synthetic oligonucleotides. An oligonucleo- 
tide with the sequence of ATCCAGC~TTAAGAACACAGACACGAGACT 
and its complementary oligonucleotide were used to substitute Arg and Lys 
residues in the cleavage site to Thr residue (see Fig. 1). An oligonucleotide 
ATCCAGGCTTAAGAATCGAGC.rGTCGAGACT  and  its  complementary 
oligonucleotides were used to change Arg-Gln-Lys sequence to Ile-Glu-Gly 
creating the recognition sequence of coagulation factor Xa (Ile-Glu-Gly- 
Arg) (see Fig.  1). The sequence of the substituted cDNAs was contirmed 
by direct DNA sequencing (Hattori and Sakaki, 1986) and the cDNAs were 
subcloned into the expression vector pSVtkneo~ (Nicolas and Berg, 1983) 
as described (Ozawa et al.,  1989). 
DNA Transfection 
Purified plasmid DNAs were introduced into mouse L-tk- cells by calcium 
phosphate precipitation together with pSVtkneoB at a  10:1 molar ratio as 
described (Ozawa et al.,  1989).  After 2 wk of G418 (1 mg/ml) selection, 
cells expressing uvomorulin were isolated by FACS and cloned. 
Antibodies 
Antibodies against the extracellular part of mature uvomorulin (anti-gp84) 
were purified as  described (Vestweber and  Kemler,  1985).  Antibodies 
against the precursor segment of uvomorulin (antiprecursor) were prepared 
as follows. A 400-bp Pst I-Pvu II fragment of uvomorulin eDNA that en- 
codes the carboxy-terminal 127 amino acid residues of the precursor seg- 
ment and the amino-terminal 7 amino acid residues of the mature protein 
was  subcloned  into  the  Pst  l-Sma  I  site  of Bluescript  KS(+)  vector 
(Stratagene Corp., La Jolla, CA) to adjust the reading frame of  the fragment 
to that of  the cloning site of protein A expression vector pRIT2T (Pharmacia 
Fine Chemicals, Uppsaia, Sweden). After digestion with Eco RI and Barn 
HI, the eDNA fragment was subcloned into Eco RI-Bam HI site of  pRIT2T. 
The protein A-fusion protein was purified on an IgG Sepharose 6 Fast Flow 
(Pharmacia Fine Chemicals) column. The fusion protein was injected into 
rabbit as described (Ringwald et al., 1987).  For affinity purification of anti- 
bodies protein A or the fusion protein (1 mg) each coupled to 1 ml of IgG 
Sepharose 6 Fast Flow (5 mg/ml of dimethyl-suberimidate in 0.1 M sodium 
borate buffer, pH 8.0 for 1 h at room temperature) were used sequentially 
to obtain antibodies specific for the precursor segment. The purified anti- 
bodies (antiprecursor) reacted with the precursor polypeptide but not with 
mature uvomorulin in immunoblot, immunoprecipitation, and immunoflu- 
orescence experiments. 
Immunoprecipitation and lmmunoblot 
Cells (1  ×  106) were labeled with 50/xCi/ml of [35S]methionine  (Amer- 
sham Corp., Arlington Heights, IL) for 16 h and lysed with PBS containing 
1% Triton X-100,  1% NP-40,  2 mM CaCI2,  and 1 mM PMSE After cen- 
trifugation supematants were incubated with affinity-purified  antibodies and 
immune complexes were collected by protein A-Sepharose CL4B (Pharma- 
cia Fine Chemicals) as described (Vestweber and Kemler, 1985). 
To analyze Ca  2+ sensitivity of uvomorulin polypeptides, cells (5  ×  105) 
were washed with PBS and incubated with 1 mi of 0.01% (wt/vol) of trypsin 
(type XI; Sigma Chemical Co., St. Louis, MO) in Hepes-buffered saline 
(HBS) containing 2 mM CaCI2 or 1 mM EGTA for 10 min at 37°C. After 
addition of 40 #1 of soybean trypsin inhibitor (0.5% in HBS; Boehringer, 
Mannheim, FRG), cells were collected and boiled in 500 ~1 of SDS-PAGE 
sample buffer (Laemmli, 1970).  Aliquots (100 t~l) were subjected to SDS- 
PAGE and immunoblot analysis was done as described (Ringwald et al., 
1987).  Treatment of cells with 0.01% (wt/vol) chymotrypsin (type VII; 
Sigma Chemical Co.) was done in a similar way. The reaction was termi- 
nated by adding PMSF at a final concentration of 1 mM. 
Cell Aggregation 
Cells were dissociated by trypsin in the presence of 2 mM CaCI2 as de- 
scribed above or by incubation with PBS containing 2 mM EDTA and 2% 
chicken serum for 10 min at room temperature. After washing with the 1:1 
mixture of HBS and DMEM containing 4% FCS, cells were resuspended 
in the same medium containing 5 tzg/ml of DNase I (Boehringer). Cells 
were allowed to aggregate for 45 min at 37°C with a constant rotation of 
70 rpm. In some experiments serum coagulation factor Xa (Boehringer) was 
added in the aggregation medium. The extent of cell aggregation was calcu- 
lated according to Nagafuchi and Takeichi (1988) by the index (No-N0/No 
where Nt is the total particle number after the incubation (45 min) and No 
is the total particle number at the initiation of incubation. 
Results 
Cell Surface Expression of Mutant Uvomorulin 
Polypeptides with the Precursor Segment 
The  putative  endoproteolytic cleavage  site  of uvomorulin 
precursor polypeptide contains two pairs of a basic arrdno 
acid doublet (Arg-Arg-Gln-Lys-Arg),  which are conserved 
in mouse uvomorulin and chicken L-CAM.  To express mu- 
tant uvomorulin polypeptide containing the precursor seg- 
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Figure 1.  Scheme of uvomorulin polypeptide and the amino acid 
sequence of wild-type and mutant polypeptides at the endoproteo- 
lytic cleavage site. pSUM-1 is an expression vector with eDNA en- 
coding wild-type uvomorulin, pSUMPT and pSUMPF are vectors 
with cDNAs that encode uvomorulin polypeptides with substitu- 
tions shown in the figure. The one-letter amino acid code is used. 
The substituted amino acids are boxed and the recognition sequence 
of blood coagulation factor Xa is underlined. 
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morulin polypeptides. L cells expressing normal (L/-1) or mutant 
uvomorulin  (LT-19 and LF-7) or untransfected L cells  (L)  were 
labeled with  [35S]methionine. Lysates were  immunoprecipitated 
with antibodies against the extracellular part of mature uvomorulin 
(anti-gp84,  lanes 1, 3, 5, and 7) or antibodies against the precursor 
segment (anti-precursor,  lanes 2, 4, 6, and 8). Immunoprecipitates 
were analyzed by 8 % PAGE. 
ment on the cell surface, we replaced this sequence by the 
recognition site (Ile-Glu-Gly-Arg) of a highly specific serum 
protease,  coagulation  factor  Xa  (Nagai  and  ThCgersen, 
1987), which is not expected to be used by endogenous pro- 
teases. The second construct contained the substitution Arg- 
Thr-Gln-Thr-Arg. A similar substitution was shown to block 
efficiently the processing of the precursor protein of influ- 
enza virus hemagglutinin glycoprotein and the precursor seg- 
ment could subsequently be removed by trypsin treatment 
(Kawaoka and Webster,  1988). For convenience this substi- 
tution is subsequently referred to as "trypsin recognition site" 
to distinguish from the "factor Xa recognition site" mentioned 
above. The respective substitutions were carried out by re- 
placing a 30-bp Rsa I-Tth III I fragment of uvomorulin cDNA 
with synthetic oligonucleotides. 
The mutant uvomorulin cDNAs were introduced into L 
cells together with the neomycin-resistant gene (neo-gene) 
and G-418-resistant cells were selected for cell surface ex- 
pression  of mutant  uvomorulin by  FACS  with  antibodies 
against the precursor segment. Transfectants were subjected 
to immunoprecipitation and immunoblot analysis using ei- 
ther affinity-purified antibodies  against  the precursor seg- 
ment (antiprecursor), or antibodies against the extracellular 
part of mature uvomorulin (anti-gp84). 
Both anti-precursor and anti-gp84 antibodies recognized 
a  140-kD precursor protein in cell lysates from LT-19 (tryp- 
sin recognition site) and LF-7 (factor Xa recognition site). 
As  shown  in Fig.  2,  lanes  3-6,  both mutant  uvomorulins 
complex with catenin c~, t5, and 7, which have the known mo- 
lecular weights of 102, 88, and 80 kD, respectively. In immu- 
noblots antiprecursor and anti-gp84 antibodies reacted ex- 
clusively  with  the  respective  140-kD  mutant  uvoromulin 
from cell lysates of LT-19 and LF-7 cells (Fig. 3, lanes 4,  7, 
and 10). The 140-kD mutant proteins differ in their molecu- 
lar weight from the endogenous uvomorulin precursor (135 
kD), which is most likely due to differences in glycosylation 
since the 140-kD proteins should contain the complex carbo- 
hydrate moieties of mature uvomorulin. In pulse-chase ex- 
periments mutant uvomorulin is also first synthesized as a 
135-kD polypeptide which is processed to the 140-kD pro- 
tein (not shown). 
Immunofluorescence tests  with antiprecursor antibodies 
revealed specific membrane staining of LT-19 and LF-7 cells 
with virtually no intracellular reaction, indicating that the 
precursor segment had no inhibitory effect on the transport 
of uvomorulin to the cell surface (not shown, but see below). 
These results clearly demonstrate that proteolytic processing 
of uvomorulin precursor polypeptides is not required for the 
assembly of the uvomorulin-catenin complex and cell sur- 
face expression of uvomorulin. 
Although proteolytic processing is efficiently inhibited in 
both mutant polypeptides it was important to demonstrate 
that the newly introduced recognition sites could indeed be 
used by the respective enzymes. LT-19 cells (trypsin recogni- 
tion site) and LF-7 cells (factor Xa recognition site) were 
treated with Ca2+/trypsin  (0.01%) or with 2 U/ml factor Xa, 
respectively.  In  both  cases  the  enzymatic treatment  con- 
verted the mutant polypeptide into 120-kD proteins (Fig. 3, 
lanes 5 and 1/). The respective 120-kD proteins were indis- 
tinguishable by their electrophoretic mobility from the 120- 
kD mature uvomorulin (compare Fig. 3, lanes 2, 5, and 1/). 
From these results it is concluded that both mutant polypep- 
tides can be converted into mature proteins by exogenous 
treatment with the respective enzyme. Assuming that the en- 
zymes do not penetrate into cells, these results suggest that 
all  of the  mutant  polypeptides are  expressed on  the  cell 
surface. 
Figure  3.  Trypsin and factor Xa digestion and Ca  2+ sensitivity of 
normal and mutant uvomorulin polypeptides. Cells expressing nor- 
mal (L/-1) and mutant (L7-19 and LF-7) uvomorulin polypeptides 
were lysed with SDS-PAGE sample buffer without trypsinization 
(lanes 1, 4, and 7) or after trypsinization in the presence (lanes 2, 
5, and 8) or in the absence of Ca  2+ (lanes 3, 6, and 9) subjected 
to immunoblot analysis using anti-gp 84 antibodies. LF-7 cells dis- 
sociated with PBS containing 2 mM EDTA and 2% chicken serum 
were incubated for 1 h in the presence (lane 11) or in the absence 
(lane 10) of factor Xa (2 U/ml) and analyzed. 
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beled LI-1,  LT-19, and LF-7 cells. Cells were treated with 0.1% tryp- 
sin/2 mM Ca  2+ for 30 min (lanes 1, 3, and 5) or 60 min (lanes 2, 
4, and 6) at 37°C and soluble material was subjected to immuno- 
precipitations. An 84-kD trypsin/Ca2+-resistant fragment is gener- 
ated from wild-type and mutant uvomorulin. 
Properties of the Extracellular Domain of  Mutant 
Uvomorulin Polypeptides 
It is well known that CaE+-dependent  CAMs are resistant to 
trypsin digestion in the presence of Ca  2÷ but are degraded if 
Ca  2÷ is omitted. By treatment of cells with trypsin in pres- 
ence or absence of Ca  2+ it can be tested whether the respec- 
tive protein parts of the  mutant uvomorulins exhibit these 
Ca2+-dependent  characteristics.  Cells  were  treated  with 
0.01% trypsin, 2 mM Ca  2+ which are the standard conditions 
for dissociating cells in Ca2+-dependent cell aggregation as- 
says (see below). Immunoblot analysis from cell lysates of 
L1-1,  LT-19  and  LF-7  cells  digested  with  CaZ÷/trypsin  or 
EGTA/trypsin gave identical results as that in the presence 
of Ca  2÷, a  120-kD protein was generated in each case (Fig. 
3, lanes 2, 5, and 8) and that in the absence of Ca  2÷ the pro- 
teins were degraded (Fig.  3,  lanes 3,  6,  and 9). 
Interestingly, LF-7 cells expressing the mutant polypep- 
tide with the factor Xa recognition site were also converted 
by  Ca2÷/trypsin treatment  into  a  120-kD  protein  with  an 
identical electrophoretic mobility (Fig. 3, lane 8).  This can 
best be explained either by trypsin cleavage in the factor Xa 
recognition site or in the vicinity of this site where in fact 
several potential trypsin cleavage sites are located.  One of 
these sites either in the precursor region or in the mature pro- 
tein part could be used by trypsin to generate a  120-kD pro- 
tein from the LF-7 mutant polypeptide. 
One  striking characteristic  of all  Ca2+-dependent CAMs 
is that the extracellular part of the proteins are even resistant 
to  extensive  tryptic  digestion  when  Ca  2+  is  present.  For 
uvomorulin,  an  84-kD  soluble  trypsin/Ca  2+  fragment can 
thus be generated that harbors the functional site(s) for cell 
adhesion  (Wheelock et al.,  1987). 
To test whether mutant polypeptides exhibit also this fea- 
ture, LI-1, LT-19 and LF-7 cells were digested with 0.1% tryp- 
sin/2  mM Ca  2+ at 37°C  for 30 or 60  min and  solubilized 
material was subjected to immunoprecipitations with anti- 
gp84 (Fig. 4). An 84-kD fragment was precipitated in each 
case indicating that the respective mature parts of the mutant 
proteins exhibit this structural  similarity to wild-type uvo- 
morulin. 
Cell Aggregation Assays of Cells with Mutant 
Uvomorulin Polypeptides 
Both mutant uvomorulin polypeptides were recognized by 
monoclonal antibody DECMA-1 that is known to inhibit cell 
aggregation (Vestweber and Kemler,  1985).  To analyze the 
adhesive properties of mutant polypeptides cells were dis- 
sociated with PBS containing 2 mM EDTA and 2 % chicken 
serum. Under these conditions, the 140-kD mutant uvomo- 
rulin  polypeptides  remained  intact  on  the  cell  surface  as 
judged by immunoblot analysis (Fig. 3). When cells were al- 
lowed to aggregate, LI-1 cells expressing mature uvomorulin 
showed strong Ca2+-dependent adhesiveness, which can be 
inhibited by monoclonal antibody DECMA-1. However, LT- 
19 and LF-7 cells expressing mutant uvomorulin polypep- 
tides or control untransfected L cells showed almost no cell 
adhesion (Fig. 5, open bars).  Thus mutant polypeptides ex- 
hibit no adhesive function in spite of having other properties 
in common with normal uvomorulin. In cell mixing experi- 
ments between LI-1 and LT-19 or LF-7 cells mutant polypep- 
tides were unable to interact with mature uvomorulin (not 
shown). This suggests that the remaining precursor segment 
in the mutant uvomorulin might interfere with adhesiveness. 
Consequently,  cells were dissociated by Ca2+/trypsin treat- 
ment under conditions which were shown to convert the 140- 
kD mutant polypeptides into  120  kD proteins  (Fig.  3).  In 
subsequent cell aggregation assays only LI-1 and LT-19 (tryp- 
sin recognition site) showed uvomorulin-dependent cell ad- 
hesion (Fig.  5, closed bars).  In contrast,  LF-7 cells (factor 
Xa recognition site) still showed no adhesiveness although 
the mutant polypeptide was converted into a protein with the 
same electrophoretic mobility as the mature uvomorulin (Fig. 
3, lane 8). These results clearly demonstrate that the removal 
of the precursor segment in LT-19 cells activates the adhesive 
function of the mutant uvomorulin polypeptide. 
The results with LF-7 cells were rather unexpected as that 
a similar conversion of the mutant polypeptide to a  120-kD 
protein did not activate the adhesive properties.  The most 
likely explanation is that the trypsin cleavage sites in LT-19 
and LF-7 mutant polypeptides were not identical but trypsin 
converted  both  mutant  proteins  to  a  similar  molecular 
weight. Thus, as stated above trypsin could either cleave in 
w  °  0.8. 
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Figure 5. Aggregation of cells ex- 
pressing normal (L/-/) or mutant 
(LT-19  and LF-7) uvomorulin poly- 
peptides. Cells dissociated by PBS 
containing 2 mM EDTA and 2% 
chicken serum (open bars), or by 
0.01% trypsin  and 2  mM CaC12 
(closed bars) were allowed to ag- 
gregate for 45 min in the presence 
of 2 mM CaC12. 
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Figure 6.  Cell aggregation in 
the presence of factor Xa. LF-7 
cells  expressing  mutant  uvo- 
morulin  with  the  factor  Xa 
recognition  site  or  untrans- 
fected L ceils were dissociated 
with 0.01% trypsin in the pres- 
ence of 2 mM CaCI2 and al- 
lowed to aggregate in the pres- 
ence of factor  Xa as indicat- 
ed. Increasing amount of fac- 
tor Xa-induced aggregation of 
LF-7 cells. 
the precursor region or in the mature protein part of LF-7 
mutant polypeptides. To distinguish between both possibili- 
ties  LF-7  cells  were  dissociated  by  Ca2+/trypsin  and  cell 
aggregation assays were performed in the presence of factor 
Xa. As shown in Fig. 6, the additional treatment of LF-7 cells 
with  factor Xa led  to  an increased  cell aggregation.  This 
aggregation was uvomorulin-dependent since it could be in- 
hibited by mAb DECMA-1  and a  similar treatment of un- 
transfected L-cells had no effect (Fig. 6). From these results 
we conclude that trypsin cleaves in the precursor segment 
near the factor Xa recognition site and that additional treat- 
ment with factor Xa removes residual precursor sequences. 
These results suggest that correct proteolytic cleavage of the 
precursor polypeptides is necessary for the acquisition of the 
cell  adhesion activity of uvomorulin.  Even few remaining 
amino acid residues as in the case of Ca2+/trypsin digestion 
of LF-7 cells could be inhibitory, indicating that the amino- 
terminal part of the mature uvomorulin has an important role 
in its adhesive properties. Concordant with this view are ex- 
periments in which chymotrypsin treatment of LT-I  9 and LF-7 
cells generated in both cases a 120-kD protein with a similar 
electrophoretic mobility as mature uvomorulin, but the cell 
adhesive properties were not activated (data not shown). 
Discussion 
From the present work we conclude that a major biological 
function of endogenous proteolytic processing is to create an 
active adhesive form of uvomorulin. We show that substitu- 
tions in the putative recognition site effectively inhibit the in- 
tracellular proteolytic processing of the precursor polypep- 
tides.  Unprocessed  polypeptides can be found  in  roughly 
similar  amounts  to  normal  uvomorulin  on  the  surface, 
demonstrating  that  intracellular  transport and cell  surface 
expression of uvomorulin can occur in the absence of proteo- 
lytic processing.  Unprocessed  uvomorulin  also  associates 
with catenins and the mature part of the proteins  show the 
typical Ca2+-dependent resistance to trypsin digestion. 
However, cells expressing the unprocessed form exhibit no 
uvomorulin-dependent cell aggregation. Proteolytic removal 
of precursor segments results in the activation of adhesive 
properties, demonstrating that the presence of the precursor 
segment suppresses the cell adhesion function. More impor- 
tant, correct proteolytic cleavage is necessary for this activa- 
tion, since cleavage at the wrong position(s) does not activate 
adhesive properties. Remarkably, incorrect proteolytic cleav- 
age can generate a 120-kD protein similar in molecular size 
to  mature uvomorulin but  does  not  initiate  adhesiveness. 
Most likely residual small peptides exhibit inhibitory effects. 
This suggests that the amino-terminal region of mature uvo- 
morulin is of critical  importance for adhesiveness. 
The molecular mechanisms of cell adhesion mediated by 
uvomorulin,  or Ca2÷-dependent CAMs in general,  are not 
known,  although a  homophilic interaction is generally ac- 
cepted. We have previously shown that the extracellular part 
of uvomorulin is largely composed of three domains with 
two putative Ca2+-binding  sites  in  each domain at precise 
positions (Ringwald et al.,  1987).  The domain structure is 
most likely essential  for the generation of correct protein 
conformation and the CaZ+-dependent  resistance to proteo- 
lytic degradation.  The amino-terminal 27 amino acid resi- 
dues of uvomorulin are not part of this domain structure but 
exhibit a 74 % identity to chicken L-CAM and a 63 % identity 
to chicken N- and mouse P-cadherin suggesting some func- 
tional significance of this region (Kemler et al.,  1989). Our 
results strongly support this notion which led us to suggest 
that the amino-terminal region contains an active site for the 
inter-molecular interaction. The presence of even small frag- 
ments of the precursor segment may prevent successful inter- 
action either by steric hindrance or by masking a recognition 
site. 
These results have to be seen in the light of recent attempts 
to localize the specificity determining sites of P- and E-cad- 
herin with the use of chimeric molecules between both CAMs 
(Nose et al.,  1990). This work demonstrated clearly that the 
binding specificities of cadherins are located in the amino- 
terminal  113 amino acid residues.  However, the results did 
not allow the determination of a single site within that region 
that could mediate binding specificity. The authors discuss 
their results by suggesting either multiple binding sites or 
that the binding specificity is determined by the conforma- 
tion of the amino terminal region unique for each CAM. The 
latter interpretation is in good agreement with the observa- 
tions presented here. 
In the light of our work, the following sequence of events 
can be considered: Uvomorulin is synthesized as a precursor 
polypeptide, whose major function might be to prevent intra- 
cellular homophilic interaction.  Proteolytic processing cre- 
ates the active form of mature uvomorulin by conformational 
changes leading to alterations in and/or the exposure of ac- 
tive binding sites.  Alternatively, proteolytic processing could 
induce self-association of uvomorulin polypeptides into oli- 
gomeric structures with improved binding properties. 
During this study it became apparent that different pro- 
teases  can  generate  120-kD  proteins  that  by  their  elec- 
trophoretic  mobility  are  indistinguishable  from  normal 
uvomorulin but which are not functional.  This observation 
might have broader biological implications.  Uvomorulin is 
the  major  adhesive  component  in  the  formation  and  the 
maintenance  of  epithelial  cell  interaction  and  has  been 
thought to act as a kind of a glue to preserve the integrity 
of an epithelial sheet (Boiler et al.,  1985; Gumbiner et al., 
1988;  Kemler et al.,  1989).  Changes in uvomorulin-medi- 
ated adhesion might be one prerequisite in the multistep mech- 
anism of carcinogenesis where epithelial cells acquire invasive 
and metastatic properties and examples of highly metastatic 
cells with a low amount of uvomorulin/E-cadherin have been 
reported (Hashimoto et al.,  1989). 
Ozawa and Kemler Proteolytic Processing and Adhesive Function  of Uvomorulin  1649 However, increased metastatic ability is not always accom- 
panied by a decrease of uvomorulin/E-cadherin (Shimoyama 
et al.,  1989). Our results have shown that incorrect proteo- 
lytic  cleavage  of uvomorulin precursor  polypeptides  give 
rise to inactive proteins that have the same apparent molecu- 
lar weight as the normal active protein.  Such a mechanism 
could also occur during carcinogenesis.  Highly metastatic 
cell  lines have been shown to have elevated levels  of pro- 
teases including chymotrypsin like proteases (Lowe and Is- 
sacs,  1984; for review see Nicolson,  1989). It may be possi- 
ble  that malproteolytic  cleavage  of uvomorulin precursor 
polypeptides could generate an inactive form that stably ex- 
pressed on the cell surface allows cells to escape from their 
adhesive environment. 
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